Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods An, Ming-Wen , Han, Yu , Meyers, Jeffrey P. , Bogaerts, Jan ... - - J. Clin. Oncol - 2015 Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-N9741
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048 Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J. Clin. Oncol - 2018 Manuscript - Secondary-not-in-original - Primary - Health Outcome - N1048
A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without Cediranib as First-Line Therapy in Advanced Non-Small Cell Lung Cancer: North Central Cancer Treatment Group Study N0528 Dy, Grace K. , Mandrekar, Sumithra J. , Nelson, Garth D. ... - - J Thorac Oncol - 2013 Manuscript - Primary - Primary - Respiratory - N0528
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance) Halfdanarson, Thorvardur R. , Foster, Nathan R. , Kim, George P. ... - - Oncologist - 2019 Manuscript - Primary - Primary - GI - N064B
Alliance A091104: A Phase II Trial of MK-2206 in patients with progressive, recurrent/metastatic adenoid cystic carcinoma Ho, Alan L , Foster, Nathan R. , Meyers, Jeffrey P. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Experimental - A091104
NCCTG N0543 (Alliance): A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma McWilliams, Robert R. , Foster, Nathan R. , Mahoney, Michelle R. ... - - Cancer - 2017 Manuscript - Primary - Primary - GI - N0543
Oral Cancer Chemotherapy Adherence and Adherence Assessment Tools: A Report from North Central Cancer Group Trial N0747 and a Systematic Review of the Literature Patel, Krishna , Foster, Nathan R. , Farrell, Ann ... - - J Cancer Educ - 2013 Manuscript - Primary - Primary - GI - NCCTG-N0747
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS with Survival after Recurrence in Stage III Colon Cancers from Phase III Adjuvant Chemotherapy Trials Sinicrope, Frank A. , Shi, Qian , Allegra, Carmen J. ... - - JAMA Oncol - 2017 Manuscript - Secondary-not-in-original - Comprehensive - Correl Sci NOS - NCCTG-N0147
Molecular markers and survival after recurrence in stage III colon cancers from NCCTG N0147 and NSABP C-08 adjuvant chemotherapy trials Sinicrope, Frank A. , Shi, Qian , Allegra, Carmen Joseph ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - N0147
Association Of Tumor Infiltrating Lymphocytes (Tils) With Molecular Subtype And Prognosis In Stage III Colon Cancers From A FOLFOX-Based Adjuvant Chemotherapy Trial: NCCTG N0147 (Alliance) Sinicrope, Frank A. , Smyrk, Thomas C. , Foster, Nathan R. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary - Primary - Correl Sci NOS - NCCTG-N0147
Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) Wilcox, Ryan E. , Shi, Qian , Sinicrope, Frank A. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary - Primary - Correl Sci NOS - N0147
Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy Zaanan, Aziz , Shi, Qian , Taieb, Julien , Alberts, Steven R. ... - - JAMA Oncol - 2018 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147
Clinical outcomes between familial and sporadic forms of colon cancer patients showing deficient DNA mismatch repair treated with adjuvant FOLFOX +/- cetuximab: A pooled analysis of the PETACC8 and NCCTG N0147 trials Zaanan, Aziz , Shi, Qian , Taieb, Julien , Alberts, Steven R. ... - - JCO Precision Oncology - 2020 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147
A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321 Zhao, Yujie , Foster, Nathan R. , Meyers, Jeffrey P. ... - - J Thorac Oncol - 2015 Manuscript - Primary - Primary - Respiratory - NCCTG-N0321
